Onderneming Structure Therapeutics Inc.
Aandelen
GPCR
US86366E1064
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
55,63 USD | -1,19% | +64,78% | +36,48% |
06/06 | Structure Therapeutics prijst verhoogd aanbod van $476 miljoen aan aandelen | MT |
03/06 | Structure Therapeutics plant aanbod van American Depositary Shares | MT |
Vakgebied
Aantal werknemers: 111
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Raymond Stevens
FOU | Founder | 60 | 01-02-19 |
Jun Yoon
DFI | Director of Finance/CFO | 46 | 01-02-19 |
Ying Li Ma
CTO | Chief Tech/Sci/R&D Officer | 50 | 01-08-22 |
Xi Chen Lin
CTO | Chief Tech/Sci/R&D Officer | 50 | 01-07-19 |
Mark Bach
CTO | Chief Tech/Sci/R&D Officer | 67 | 01-06-21 |
Lani Ibarra
CTO | Chief Tech/Sci/R&D Officer | - | - |
Tony Peng
LAW | General Counsel | - | - |
Karen S. Wright
AUD | Comptroller/Controller/Auditor | 69 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sharon Tetlow
BRD | Director/Board Member | 64 | 29-03-22 |
Ted Love
BRD | Director/Board Member | 65 | 03-08-23 |
Eric Dobmeier
BRD | Director/Board Member | 55 | 01-12-22 |
Daniel Welch
CHM | Chairman | 66 | 19-01-22 |
Ramy Farid
BRD | Director/Board Member | 59 | 01-04-19 |
Raymond Stevens
FOU | Founder | 60 | 01-02-19 |
Jun Yoon
DFI | Director of Finance/CFO | 46 | 01-02-19 |
Director/Board Member | 64 | 01-12-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 2 161 | 0 | 0 | 76,06 % |
Aandeel B | 0 | 32 857 | 0 | 0 | |
Aandeel C | 1 | 139 794 124 | 106 321 015 ( 76,06 %) | 0 | |
Aandeel D | 0 | 12 800 | 0 | 0 | |
Aandeel E | 0 | 19 200 | 0 | 0 |
Bedrijfsgegevens
Structure Therapeutics, Inc.
601 Gateway Boulevard Suite 900
94080, South San Francisco
+
http://www.structuretx.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+36,48% | 2,62 mld. | |
+19,33% | 125 mld. | |
+13,95% | 109 mld. | |
-3,53% | 24,74 mld. | |
+2,71% | 22,67 mld. | |
-9,95% | 18,14 mld. | |
-41,48% | 16,67 mld. | |
-12,62% | 16,64 mld. | |
+0,99% | 13,45 mld. | |
+21,79% | 11,32 mld. |
- Beurs
- Aandelen
- Koers GPCR
- Onderneming Structure Therapeutics Inc.